Neuropathic diabetic foot ulcers - evidence-to-practice

International Journal of General Medicine

Volumn 5, Issue , 2012, Pages 129-134

  Ndip, Agbor ^a,b,c   Ebah, Leonard ^a   Mbako, Aloysius ^d  

^a MANCHESTER ROYAL INFIRMARY   (United Kingdom)

^b ROYAL BOLTON HOSPITAL   (United Kingdom)

^c UNIVERSITY OF MANCHESTER   (United Kingdom)

^d WREXHAM MAELOR HOSPITAL   (United Kingdom)

Author keywords

Diabetic foot ulcers; Foot ulcers; Neuropathic foot ulcers

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; GRANULOCYTE COLONY STIMULATING FACTOR; LINEZOLID; RECOMBINANT PLATELET DERIVED GROWTH FACTOR; SULTAMICILLIN; ANTIBIOTIC AGENT; PLACEBO; SILICONE OIL;

ANTIBIOTIC THERAPY; CLINICAL PRACTICE; COST EFFECTIVENESS ANALYSIS; DEBRIDEMENT; DIABETIC FOOT; DIABETIC NEUROPATHY; EVIDENCE BASED PRACTICE; GRANULATION TISSUE; HEALTH CARE COST; HONEY; HUMAN; HYPERBARIC OXYGEN; OUTCOME ASSESSMENT; PATIENT CARE; PATIENT EDUCATION; PERIPHERAL VASCULAR DISEASE; PROTEIN ANALYSIS; PROTEIN FUNCTION; REVIEW; SELF CARE; SELF EVALUATION; SYSTEMATIC REVIEW; VACUUM ASSISTED CLOSURE; WOUND DRESSING; WOUND HEALING; CAST APPLICATION; CLINICAL ASSESSMENT; CLINICAL EFFECTIVENESS; COST OF ILLNESS; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; EVIDENCE BASED MEDICINE; FOOT CARE; FOOT DISEASE; GRAM NEGATIVE INFECTION; GRAM POSITIVE INFECTION; HYDROGEL; INFECTION; NONHUMAN; PREVENTION STUDY; RECURRENT DISEASE; SHOE; STAPHYLOCOCCUS INFECTION; STREPTOCOCCUS INFECTION; TEMPERATURE MEASUREMENT; TREATMENT PLANNING; UNSPECIFIED SIDE EFFECT; WOUND HEALING IMPAIRMENT;

EID: 84857066326     PISSN: None     EISSN: 11787074     Source Type: Journal    
DOI: 10.2147/IJGM.S10328     Document Type: Review

References (41)

1. Singh N, Armstrong DG, Lipsky BA. Preventing foot ulcers in patients with diabetes. JAMA. 2005;293(2):217-228.
2. Reiber GE, Vileikyte L, Boyko EJ, et al. Causal pathways for incident lower-extremity ulcers in patients with diabetes from two settings. Diabetes Care. 1999;22(1):157-162.
3. Boulton AJ. The pathogenesis of diabetic foot problems: an overview. Diabet Med. 1996;13:S12-S16.
4. Ndip A, Jude EB. Emerging evidence for neuroischemic diabetic foot ulcers: model of care and how to adapt practice. Int J Low Extrem Wounds. 2009;8(2):82-94.
5. Ramsey SD, Newton K, Blough D, et al. Incidence, outcomes, and cost of foot ulcers in patients with diabetes. Diabetes Care. 1999;22(3): 382-387.
6. Tennvall GR, Apelqvist J, Eneroth M. Costs of deep foot infections in patients with diabetes mellitus. Pharmacoeconomics. 2000;18(3): 225-238.
7. Prompers L, Huijberts M, Schaper N, et al. Resource utilisation and costs associated with the treatment of diabetic foot ulcers. Prospective data from the Eurodiale Study. Diabetologia. 2008;51(10):1826-1834.
8. Spencer S. Pressure relieving interventions for preventing and treating diabetic foot ulcers. Cochrane Database Syst Rev. 2000;3:CD002302.
9. Edwards J, Stapley S. Debridement of diabetic foot ulcers. Cochrane Database Syst Rev. 2010;1:CD003556.
10. Piaggesi A, Schipani E, Campi F, et al. Conservative surgical approach versus non-surgical management for diabetic neuropathic foot ulcers: a randomized trial. Diabet Med. 1998;15(5):412-417.
11. Markevich YO, McLeod-Roberts J, Mousley M, Melloy E. Maggot therapy for diabetic neuropathic foot wounds. Diabetologia: Proceedings of the 36th Annual meeting of the European Association for the Study of Diabetes. 2000;43:Suppl1:A15.
12. Bowling FL, Salgami EV, Boulton AJ. Larval therapy: a novel treatment in eliminating methicillin-resistant Staphylococcus aureus from diabetic foot ulcers. Diabetes Care. 2007;30(2):370-371.
13. Joseph E, Hamori CA, Bergman S, Roaf E, Swann NF, Anastasi GW. A prospective randomized trial of vacuum-assisted closure versus standard therapy of chronic nonhealing wounds. Wounds. 2000;12(3): 60-67.
14. Moisidis E, Heath T, Boorer C, Ho K, Deva AK. A prospective, blinded, randomized, controlled clinical trial of topical negative pressure use in skin grafting. Plast Reconstr Surg. 2004;114(4):917-922.
15. Armstrong DG, Lavery LA; Diabetic Foot Study Consortium. Negative pressure wound therapy after partial diabetic foot amputation: a multicentre, randomised controlled trial. Lancet. 2005;366(9498):1704-1710.
16. Eneroth M, van Houtum WH. The value of debridement and vacuumassisted closure (VAC) therapy in diabetic foot ulcers. Diabetes Metab Res Rev. 2008;24 Suppl 1:S76-S80.
17. Ubbink DT, Westerbos SJ, Evans D, Land L, Vermeulen H. Topical negative pressure for treating chronic wounds. Cochrane Database Syst Rev. 2008;3:CD001898.
18. Steed DL. Clinical evaluation of recombinant human platelet-derived growth factor for the treatment of lower extremity ulcers. Plast Reconstr Surg. 2006;117(7 Suppl):143S-149S.
19. Steed DL. Clinical evaluation of recombinant human platelet-derived growth factor for the treatment of lower extremity diabetic ulcers. J Vasc Surg. 1995;21(1):71-81.
20. Wieman TJ, Smiell JM, Su YC. Efficacy and safety of a topical gel formulation of recombinant human platelet-derived growth factor-BB (becaplermin) in patients with chronic neuropathic diabetic ulcers. A phase III randomized placebo-controlled double-blind study. Diabetes Care. 1998;21(5):822-827.
21. Cruciani M, Lipsky BA, Mengoli C, de Lalla F. Granulocyte-colony stimulating factors as adjunctive therapy for diabetic foot infections. Cochrane Database Syst Rev. 2009;3:CD006810.
22. Cruciani M, Mengoli C, Lipsky BA, De Lalla F. Are granulocyte colony- stimulating factors beneficial in treating diabetic foot infections?: A meta-analysis. Diabetes Care. 2005;28(2):454-460.
23. Shukrimi A, Sulaiman AR, Halim AY, Azril A. A comparative study between honey and povidone iodine as dressing solution for Wagner type II diabetic foot ulcers. Med J Malaysia. 2008;63(1):44-46.
24. Hinchliffe RJ, Valk GD, Apelqvist J, et al. A systematic review of the effectiveness of interventions to enhance the healing of chronic ulcers of the foot in diabetes. Diabetes Metab Res Rev. 2008;24 Suppl 1: S119-S144.
25. Kranke P, Bennett M, Roeckl-Wiedmann I, Debus S. Hyperbaric oxygen therapy for chronic wounds. Cochrane Database Syst Rev. 2004;2:CD004123.
26. Lipsky BA, Itani K, Norden C; Linezolid Diabetic Foot Infections Study Group. Treating foot infections in diabetic patients: a randomized, multicenter, open-label trial of linezolid versus ampicillin-sulbactam/ amoxicillin-clavulanate. Clin Infect Dis. 2004;38(1):17-24.
27. Litzelman DK, Slemenda CW, Langefeld CD, et al. Reduction of lower extremity clinical abnormalities in patients with non-insulin-dependent diabetes mellitus. A randomized, controlled trial. Ann Intern Med. 1993;119(1):36-41.
28. Donohoe ME, Fletton JA, Hook A, et al. Improving foot care for people with diabetes mellitus - a randomized controlled trial of an integrated care approach. Diabet Med. 2000;17(8):581-587.
29. Malone JM, Snyder M, Anderson G, Bernhard VM, Holloway GA Jr, Bunt TJ. Prevention of amputation by diabetic education. Am J Surg. 1989;158(6):520-523; discussion 3-4.
30. Lincoln NB, Radford KA, Game FL, Jeffcoate WJ. Education for Secondary prevention of foot ulcers in people with diabetes: a randomized controlled trial. Diabetologia. 2008;51(11):1954-1961.
31. Armstrong DG, Holtz-Neiderer K, Wendel C, Mohler MJ, Kimbriel HR, Lavery LA. Skin temperature monitoring reduces the risk for diabetic foot ulceration in high-risk patients. Am J Med. 2007;120(12): 1042-1046.
32. van Schie CH, Whalley A, Armstrong DG, Vileikyte L, Boulton AJ. The effect of silicone injections in the diabetic foot on peak plantar pressure and plantar tissue thickness: a 2-year follow-up. Arch Phys Med Rehabil. 2002;83(7):919-923.
33. van Schie CH, Whalley A, Vileikyte L, Wignall T, Hollis S, Boulton AJ. Efficacy of injected liquid silicone in the diabetic foot to reduce risk factors for ulceration: a randomized double-blind placebo-controlled trial. Diabetes Care. 2000;23(5):634-638.
34. American Diabetes Association. Consensus Development Conference on Diabetic Foot Wound Care: April 7-8, 1999, Boston, Massachusetts. Diabetes Care. 1999;22(8):1354-1360.
35. Armstrong DG, Nguyen HC, Lavery LA, van Schie CH, Boulton AJ, Harkless LB. Off-loading the diabetic foot wound: a randomized clinical trial. Diabetes Care. 2001;24(6):1019-1022.
36. Boulton AJ. Pressure and the diabetic foot: clinical science and offloading techniques. Am J Surg. 2004;187(5A):17S-24S.
37. Armstrong DG, Lavery LA, Wu S, Boulton AJ. Evaluation of removable and irremovable cast walkers in the healing of diabetic foot wounds: a randomized controlled trial. Diabetes Care. 2005;28(3):551-554.
38. Katz IA, Harlan A, Miranda-Palma B, et al. A randomized trial of two irremovable off-loading devices in the management of plantar neuropathic diabetic foot ulcers. Diabetes Care. 2005;28(3):555-559.
39. Lipsky BA, Armstrong DG, Citron DM, Tice AD, Morgenstern DE, Abramson MA. Ertapenem versus piperacillin/tazobactam for diabetic foot infections (SIDESTEP): prospective, randomised, controlled, double- blinded, multicentre trial. Lancet. 2005;366(9498): 1695-1703.
40. Lavery LA, Higgins KR, Lanctot DR, et al. Home Monitoring of Foot Skin Temperatures to Prevent Ulceration. Diabetes Care. 2004;27(11):2642-2647.
41. Lavery LA, Higgins KR, Lanctot DR, et al. Preventing Diabetic Foot Ulcer Recurrence in High-Risk Patients. Diabetes Care. 2007;30(1):14-20.